Search Results 1491-1500 of 32708 for oral

1. Ruxolitinib Phosphate (Oral JAK Inhibitor INCB18424) in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin Lymphoma - Mayo Clinic

   Ruxolitinib Phosphate (Oral JAK Inhibitor INCB18424) in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin ...

2. Aliskiren and hydrochlorothiazide (oral route) - Side effects & dosage - Mayo Clinic

   For oral dosage form (tablets):. For high blood pressure: Adults—At first, one tablet containing 150 milligrams (mg) of aliskiren and 12.5 mg of ...

3. A Study to Evaluate the Cognitive Effects of Oral p38 Alpha Kinase Inhibitor Neflamapimod in Dementia with Lewy Bodies - Mayo Clinic

   A Study to Evaluate the Cognitive Effects of Oral p38 Alpha Kinase Inhibitor Neflamapimod in Dementia with Lewy Bodies · Overview · Participation eligibility.

4. Efficacy and Safety Extension Study of Oral Edaravone Administered in Subjects With ALS - Mayo Clinic

   The purpose of this study is to evaluate and compare the effectiveness of two dosing regimens of oral edaravone in subjects with amyotrophic lateral ...

5. A Study to Evaluate Effectiveness of 2 Doses of Oral CXA-10 in Pulmonary Arterial Hypertension (PAH) - Mayo Clinic

   A Study to Evaluate Effectiveness of 2 Doses of Oral CXA-10 in Pulmonary Arterial Hypertension (PAH) · Overview · Participation eligibility · Participating Mayo ...

6. Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS - Mayo Clinic

   This study will evaluate whether prolonged oral levosimendan can preserve respiratory function more effectively than placebo, resulting in better patient ...

7. Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS - Mayo Clinic

   The purpose of this study is to confirm that levosimendan can significantly improve respiratory function measured by supine slow vital capacity (SVC) in ...

8. Sofosbuvir, velpatasvir, and voxilaprevir (oral route) - Side effects & dosage - Mayo Clinic

   For oral dosage form (tablets):. For hepatitis C virus infection that has been previously treated with other medicines: Adults—One tablet (400 milligrams [mg] ...

9. Drugs and Supplements that Start with C - Mayo Clinic

   Ca · Cabazitaxel (intravenous route) · Cabenuva. Also known as. Cabotegravir and rilpivirine (intramuscular route) · Cabergoline (oral route) · Cabometyx. Also ...

10. Drugs and Supplements that Start with A - Mayo Clinic

    ACT Amphetamine XR - 10MG Tablet. Also known as. Dextroamphetamine and amphetamine (oral route). ACT Amphetamine XR - 15MG Tablet. Also known as.